Zealand Pharma A/S ADR (ZEAL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 2,423 | 1,788 | 2,171 | 6,333 | 1,598 |
| Gross Profit | 2,423 | 1,788 | 2,171 | 6,333 | 1,598 |
| Operating Expenses | 23,545 | 15,411 | 19,066 | 12,371 | 15,614 |
| Operating Income | -21,122 | -13,623 | -16,895 | -6,038 | -14,017 |
| Interest Expense | 587 | 2,005 | 356 | 1,018 | 109 |
| Other Income | 1,130 | 310 | -18 | 161 | 68 |
| Pre-tax Income | -20,579 | -15,318 | -17,268 | -6,895 | -14,058 |
| Income Tax | -220 | -227 | -218 | -217 | -203 |
| Net Income Continuous | -20,359 | -15,091 | -17,050 | -6,678 | -13,855 |
| Net Income | $-20,359 | $-15,091 | $-17,050 | $-6,678 | $-13,855 |
| EPS Basic Total Ops | -0.67 | -0.49 | -0.56 | -0.23 | -0.54 |
| EPS Basic Continuous Ops | -0.66 | -0.49 | -0.56 | -0.23 | -0.54 |
| EPS Diluted Total Ops | -0.67 | -0.49 | -0.56 | -0.23 | -0.54 |
| EPS Diluted Continuous Ops | -0.66 | -0.49 | -0.56 | -0.23 | -0.54 |
| EBITDA(a) | $-21,122 | $-13,623 | $-16,895 | $-6,038 | $-14,017 |